Literature DB >> 20596032

Expression of cell-cell interacting genes distinguishes HLXB9/TEL from MLL-positive childhood acute myeloid leukemia.

S Wildenhain, C Ruckert, S Röttgers, J Harbott, W-D Ludwig, F R Schuster, K Beldjord, V Binder, R Slany, J Hauer, A Borkhardt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20596032     DOI： 10.1038/leu.2010.146

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  9 in total

1.  The embryonic transcription factor Hlxb9 is a menin interacting partner that controls pancreatic β-cell proliferation and the expression of insulin regulators.

Authors:  Kerong Shi; Vaishali I Parekh; Swarnava Roy; Shruti S Desai; Sunita K Agarwal
Journal:  Endocr Relat Cancer       Date:  2013-02-18       Impact factor: 5.678

2.  The homeobox gene HLXB9 is upregulated in a morphological subset of poorly differentiated hepatocellular carcinoma.

Authors:  Ludwig Wilkens; Rolf Jaggi; Caroline Hammer; Daniel Inderbitzin; Olivier Giger; Nils von Neuhoff
Journal:  Virchows Arch       Date:  2011-04-12       Impact factor: 4.064

3.  Homeobox protein HB9 binds to the prostaglandin E receptor 2 promoter and inhibits intracellular cAMP mobilization in leukemic cells.

Authors:  Sarah Wildenhain; Deborah Ingenhag; Christian Ruckert; Özer Degistirici; Martin Dugas; Roland Meisel; Julia Hauer; Arndt Borkhardt
Journal:  J Biol Chem       Date:  2012-10-08       Impact factor: 5.157

4.  Novel insights into the role of aberrantly expressed MNX1 (HLXB9) in infant acute myeloid leukemia.

Authors:  Juerg Schwaller
Journal:  Haematologica       Date:  2019-01       Impact factor: 9.941

5.  The homeobox transcription factor HB9 induces senescence and blocks differentiation in hematopoietic stem and progenitor cells.

Authors:  Deborah Ingenhag; Sven Reister; Franziska Auer; Sanil Bhatia; Sarah Wildenhain; Daniel Picard; Marc Remke; Jessica I Hoell; Andreas Kloetgen; Dennis Sohn; Reiner U Jänicke; Gesine Koegler; Arndt Borkhardt; Julia Hauer
Journal:  Haematologica       Date:  2018-08-09       Impact factor: 9.941

6.  Engineered model of t(7;12)(q36;p13) AML recapitulates patient-specific features and gene expression profiles.

Authors:  Denise Ragusa; Ylenia Cicirò; Concetta Federico; Salvatore Saccone; Francesca Bruno; Reza Saeedi; Cristina Sisu; Cristina Pina; Arturo Sala; Sabrina Tosi
Journal:  Oncogenesis       Date:  2022-09-03       Impact factor: 6.524

7.  A Novel Three-Colour Fluorescence in Situ Hybridization Approach for the Detection of t(7;12)(q36;p13) in Acute Myeloid Leukaemia Reveals New Cryptic Three Way Translocation t(7;12;16).

Authors:  Abdulbasit Naiel; Michael Vetter; Olga Plekhanova; Elena Fleischman; Olga Sokova; Grigory Tsaur; Jochen Harbott; Sabrina Tosi
Journal:  Cancers (Basel)       Date:  2013-03-11       Impact factor: 6.639

Review 8.  Paediatric acute myeloid leukaemia with the t(7;12)(q36;p13) rearrangement: a review of the biological and clinical management aspects.

Authors:  Sabrina Tosi; Yasser Mostafa Kamel; Temitayo Owoka; Concetta Federico; Tony H Truong; Salvatore Saccone
Journal:  Biomark Res       Date:  2015-10-05

9.  LncRNA MNX1-AS1 promotes progression of intrahepatic cholangiocarcinoma through the MNX1/Hippo axis.

Authors:  Fengwei Li; Qinjunjie Chen; Hui Xue; Lei Zhang; Kui Wang; Feng Shen
Journal:  Cell Death Dis       Date:  2020-10-22       Impact factor: 8.469
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.